{"id":"buformin","rwe":[{"pmid":"41725923","year":"2026","title":"Ligand-Based Pharmacophore Mapping and Virtual Screening for the Search of Biguanide-Like Molecules With Antidiabetic Potentials Targeting Liver Kinase B1.","finding":"","journal":"Biochemistry research international","studyType":"Clinical Study"},{"pmid":"41252910","year":"2026","title":"Fluorinated COF-based piezo-triboelectric nanocatalytic probe for SERS quantification analysis of trace metformin.","finding":"","journal":"Talanta","studyType":"Clinical Study"},{"pmid":"40430574","year":"2025","title":"Metformin-Induced Apoptosis Is Mediated Through Mitochondrial VDAC1.","finding":"","journal":"Pharmaceuticals (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"38956919","year":"2025","title":"Sustainable Synthesis of Guanidine Derivatives and Computational Assessment of their Antidiabetic Efficacy.","finding":"","journal":"Endocrine, metabolic & immune disorders drug targets","studyType":"Clinical Study"},{"pmid":"38318350","year":"2024","title":"Insights into the action of the pharmaceutical metformin: Targeted inhibition of the gut microbial enzyme agmatinase.","finding":"","journal":"iScience","studyType":"Clinical Study"}],"tags":[{"label":"buformin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"A10BA03","category":"atc"},{"label":"Active","category":"status"},{"label":"Diabetes mellitus type 2","category":"indication"},{"label":"Hypoglycemic Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=BUFORMIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:58:17.751083+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:58:23.417550+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BUFORMIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:58:23.771588+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL39736/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:58:24.478137+00:00"}},"allNames":"butformin","offLabel":[],"synonyms":["buformin","buformine","butformin","butylbiguanide","butyldiguanide","buformin hydrochloride","buformin HCl"],"timeline":[],"brandName":"Butformin","ecosystem":[{"indication":"Diabetes mellitus type 2","otherDrugs":[{"name":"acarbose","slug":"acarbose","company":"Bayer Hlthcare"},{"name":"acetohexamide","slug":"acetohexamide","company":"Lilly"},{"name":"albiglutide","slug":"albiglutide","company":"Glaxosmithkline Llc"},{"name":"alogliptin","slug":"alogliptin","company":"Takeda Pharms Usa"}],"globalPrevalence":537000000}],"mechanism":{"modality":"Small Molecule","drugClass":"buformin","explanation":"","oneSentence":"","technicalDetail":"Butformin exerts its effects by inhibiting the enzyme phosphofructokinase-1, a key regulator of glycolysis, which in turn reduces glucose production in the liver."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/423","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=BUFORMIN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BUFORMIN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:04:45.502000","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:58:26.141296+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"metformin","drugSlug":"metformin","fdaApproval":"1995-03-03","patentExpiry":"May 1, 2035","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"buformin","indications":{"approved":[{"name":"Diabetes mellitus type 2","source":"DrugCentral","snomedId":44054006,"regulator":"FDA","usPrevalence":37300000,"globalPrevalence":537000000,"prevalenceMethod":"curated","prevalenceSource":"IDF Diabetes Atlas, 2024"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"metformin","brandName":"metformin","genericName":"metformin","approvalYear":"1995","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT02871869","phase":"PHASE2,PHASE3","title":"Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma","status":"UNKNOWN","sponsor":"Xinjiang Medical University","startDate":"2016-09","conditions":["Diffuse, Large B-Cell, Lymphoma"],"enrollment":316,"completionDate":"2021-12"},{"nctId":"NCT02476760","phase":"","title":"Incretin-based Drugs and Acute Pancreatitis","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2014-03","conditions":["Diabetes Mellitus, Type 2"],"enrollment":1417914,"completionDate":"2015-04"},{"nctId":"NCT02456428","phase":"","title":"Incretin-based Drugs and the Risk of Heart Failure","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2014-03","conditions":["Type 2 Diabetes Mellitus"],"enrollment":1499650,"completionDate":"2015-05"},{"nctId":"NCT02475499","phase":"","title":"Incretin-based Drugs and Pancreatic Cancer","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2014-03","conditions":["Diabetes Mellitus, Type 2"],"enrollment":886172,"completionDate":"2015-04"},{"nctId":"NCT01584232","phase":"PHASE3","title":"A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2012-04","conditions":["Type 2 Diabetes Mellitus"],"enrollment":361,"completionDate":"2013-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"W2115E9C7B","CHEBI":"CHEBI:3209","INN_ID":"2004","UMLSCUI":"C0006359","chemblId":"CHEMBL39736","ChEMBL_ID":"CHEMBL39736","KEGG_DRUG":"D00595","DRUGBANK_ID":"DB04830","PDB_CHEM_ID":" BFR","PUBCHEM_CID":"2468","SECONDARY_CAS_RN":"1190-53-0","MESH_DESCRIPTOR_UI":"D002026"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"4.62 hours","clearance":"6.58 mL/min/kg","fractionUnbound":"0.9%","volumeOfDistribution":"1.84 L/kg"},"publicationCount":179,"therapeuticAreas":["Metabolic"],"atcClassification":{"source":"DrugCentral","atcCode":"A10BA03","allCodes":["A10BA03"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026","pmid":"41725923","title":"Ligand-Based Pharmacophore Mapping and Virtual Screening for the Search of Biguanide-Like Molecules With Antidiabetic Potentials Targeting Liver Kinase B1.","journal":"Biochemistry research international"},{"date":"2026 Mar 1","pmid":"41252910","title":"Fluorinated COF-based piezo-triboelectric nanocatalytic probe for SERS quantification analysis of trace metformin.","journal":"Talanta"},{"date":"2025 May 20","pmid":"40430574","title":"Metformin-Induced Apoptosis Is Mediated Through Mitochondrial VDAC1.","journal":"Pharmaceuticals (Basel, Switzerland)"},{"date":"2025","pmid":"38956919","title":"Sustainable Synthesis of Guanidine Derivatives and Computational Assessment of their Antidiabetic Efficacy.","journal":"Endocrine, metabolic & immune disorders drug targets"},{"date":"2024 Feb 16","pmid":"38318350","title":"Insights into the action of the pharmaceutical metformin: Targeted inhibition of the gut microbial enzyme agmatinase.","journal":"iScience"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"withdrawn","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:58:26.141296+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}